What is the correct injection method for tilsiparatide/tilpotide?

Tirzepatide is a new glucagon-like peptide-1 (GLP-1) receptor agonist, commonly used to treat type 2 diabetes. Correct injection method is crucial to ensure the efficacy and safety of the drug. Before starting injections, patients and caregivers should receive appropriate training on correct injection techniques.

Before injecting tisiparatide, patients need to prepare the required equipment, including single-dose vials, suitable dose syringes (such as 1mL syringes capable of measuring0.5mL), alcohol cotton balls and gauze, etc. Before use, be sure to carefully check the appearance of the tilsiparatide solution. It should be transparent, colorless to slightly yellow. If particulate matter or discoloration is found in the medicinal solution, use must be stopped immediately and avoid injecting potentially risky medications.

The best time to inject tisiparatide is once a week, and patients can choose to inject it at any time of the day, and there is no need to specify a relationship with meals. Therefore, patients can decide when to inject based on their personal lifestyle habits and schedules, which can help improve compliance. Before injecting, patients should choose an appropriate injection site, with subcutaneous injections in the abdomen, thigh, or upper arm usually recommended. When selecting the injection site, care should be taken to avoid repeated injections at the same location, and the site should be rotated for each injection to reduce the risk of skin ** and lipoatrophy.

When giving an injection, first clean the selected injection site with an alcohol swab to reduce the risk of infection. Next, draw the desired dose of tilsiparatide from the vial. Before the injection, the patient can gently pinch the skin to form a small fold, and then quickly insert the needle under the skin at an angle of about 90 degrees. After ensuring that the needle is fully inserted, slowly inject the drug and keep the needle under the skin for about 10 seconds after the injection is completed to ensure that the drug is fully absorbed into the body. Then remove the needle and gently press the injection site with gauze to help stop bleeding.

In addition, after the injection is completed, patients should properly dispose of used needles and syringes, always following local regulations for medical waste disposal. To ensure long-term efficacy and safety, patients should communicate with their doctors regularly to understand treatment progress and the need to adjust the injection plan.

Reference materials:https://www.drugs.com/tirzepatide.html